Feedback / Questions
BIA 28-6156 - BIAL
Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL
https://www.businesswire.com/news/home/20260525810705/en/Bial-Announces-Completion-of-Phase-2b-ACTIVATE-Study-with-BIA-28-6156-in-GBA1-Associated-Parkinsons
May 26, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next